go to main content
3 December 2018

Researchers at Radboudumc have improved the immune stimulatory potential of dendritic cell vaccination for patients with blood cell cancer. A small-scale clinical study shows that their improved therapy is safe. This successful project is made possible by the ZonMw programma translational research which aims to bring promising scientific findings faster to the patients.

Read here the interview in ZonMW Mediator 32 (only available in Dutch), with Harry Dolstra and Willemijn Hobo, theme Cancer development and immune defense, about how to make dentritic cells more active.